Aiming to expand its reach to mass spectrometry users, Invitrogen has launched a line of proteomics kits and reagents and has partnered with life-science rival Applied Biosystems to co-market products to the mass spec market.

The alliance is the latest in a series of acquisitions and partnerships that have pushed Invitrogen into new markets and set the stage for what the company hopes will be significant revenue growth both near and long term.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.